Beijing Supreme Life Pharmaceutical Technology
CompanyChina
Beijing Supreme Life Pharmaceutical Technology develops 2 assets, the furthest in phase 2 (Dihuang Baoyuan Granules in diabetes). Mostly other acting on Insulin/IGF-1 signalling; based in China.
- 2
- Assets
- Furthest stage
- Phase 2
- 1
- Trial
- 0
- Signals
Pipeline
2Traditional Chinese herbal formulation regulating blood glucose and metabolic homeostasis
Phase 2, Other, Insulin/IGF-1 signalling, diabetes, type 2 diabetes
Traditional Chinese herbal formulation improving insulin sensitivity and glycemic control
Phase 2, Other, Insulin/IGF-1 signalling, diabetes, type 2 diabetes
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Similar companies6